News Story: Full Text
Sponsored By
Cleveland Clinic Brain Tumor and Neuro-Oncology Center
Please Click On The Above Banner For More Details
Braintumor Website


University of Minnesota First in U.S. to Offer New Targeted Therapy for Recurrent Brain Tumors


Al Musella's Comments: (This is his personal views and are not necessarily the views of the Musella Foundation!)

 This refers to the Gamma Tiles that I wrote about a few weeks ago. They are implantable wafers that slowly release radiation to the tumor bed and were recently approved by the FDA.  We will have a webinar on this treatment in May during brain tumor awareness month!  Watch for the announcement as it gets closer.  


Posted on: 02/14/2019

University of Minnesota First in U.S. to Offer New Targeted Therapy for Recurrent Brain Tumors

 




Click HERE to return to brain tumor news headlines


Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740